Study Highlights Use of PIMs in US Adults With Multimorbidity, Polypharmacy

August 02, 2021 11:00pm

The study was conducted to shed more light on the growing issue of polypharmacy, an issue that is expected to increase as the US population ages.

Neurocognitive Decline Seen Among Binge Drinkers Living With HIV
Developing a Model to Predict and Prevent Readmission in Patients With Cirrhosis
Study Identifies Potential Biomarkers for MS-Related Cognitive Decline
Does Low Iron Intake Impact Migraineurs?